Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: A possible mechanism to explain arsenic multi-target action

Tumor Biology

Volumn 33, Issue 1, 2012, Pages 157-172

  Ghaffari, Seyed H ^a   Bashash, Davood ^a   Dizaji, Majid Zaki ^a   Ghavamzadeh, Ardeshir ^a   Alimoghaddam, Kamran ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute promyelocytic leukemia; Apoptosis; Arsenic trioxide; MicroRNA

Indexed keywords

ARSENIC TRIOXIDE; CASPASE 3; MICRORNA;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE TARGETING; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SNORD47 GENE; SNORD48 GENE; U6 GENE;

EID: 83655163694     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0259-1     Document Type: Article

References (71)

1. JH Martens, et al. 2010 PML-RARalpha/RXR alters the epigenetic landscape in acute promyelocytic leukemia Cancer Cell 17 2 173 185 20159609 10.1016/j.ccr.2009.12.042 1:CAS:528:DC%2BC3cXlt1Kls7k%3D
2. H de The Z Chen 2010 Acute promyelocytic leukaemia: novel insights into the mechanisms of cure Nat Rev Cancer 10 11 775 783 20966922 10.1038/nrc2943
3. S Sell 2005 Leukemia: stem cells, maturation arrest, and differentiation therapy Stem Cell Rev 1 3 197 205 17142856 10.1385/SCR:1:3:197 1:CAS:528:DC%2BD28XhtVOjt74%3D (Pubitemid 41737096)
4. A Ghavamzadeh, et al. 2006 Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy Ann Oncol 17 1 131 134 16227315 10.1093/annonc/mdj019 1:STN:280:DC%2BD2MnntFKiug%3D%3D (Pubitemid 43033852)
5. SH Ghaffari, et al. 2006 Real-time PCR analysis of PML-RAR alpha in newly diagnosed acute promyelocytic leukaemia patients treated with arsenic trioxide as a front-line therapy Ann Oncol 17 10 1553 1559 16831853 10.1093/annonc/mdl150 1:STN:280:DC%2BD28rnsFylug%3D%3D (Pubitemid 44542043)
6. GB Zhou, et al. 2007 Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy Philos Trans R Soc Lond B Biol Sci 362 1482 959 971 17317642 10.1098/rstb.2007.2026 1:CAS:528:DC%2BD2sXotVOgurc%3D (Pubitemid 47056795)
7. WH Miller Jr, et al. 2002 Mechanisms of action of arsenic trioxide Cancer Res 62 14 3893 3903 12124315 1:CAS:528:DC%2BD38XlsV2lsrg%3D (Pubitemid 34792653)
8. XW Zhang, et al. 2010 Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML Science 328 5975 240 243 20378816 10.1126/science.1183424 1:CAS:528:DC%2BC3cXkt1Cgt7k%3D
9. XH Jiang, et al. 2001 Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3 Int J Cancer 91 2 173 179 11146441 10.1002/1097-0215(200002)9999:9999<::AID- IJC1039>3.0.CO;2-D 1:CAS:528:DC%2BD3MXot1Kjsg%3D%3D (Pubitemid 32041736)
10. DA Carney 2008 Arsenic trioxide mechanisms of action-looking beyond acute promyelocytic leukemia Leuk Lymphoma 49 10 1846 1851 18949607 10.1080/10428190802464745 1:CAS:528:DC%2BD1cXht12isb%2FF
11. R Visone CM Croce 2009 MiRNAs and cancer Am J Pathol 174 4 1131 1138 19264914 10.2353/ajpath.2009.080794 1:CAS:528:DC%2BD1MXksVOksL0%3D
12. R Hummel DJ Hussey J Haier 2010 MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types Eur J Cancer 46 2 298 311 19948396 10.1016/j.ejca.2009.10.027 1:CAS:528:DC%2BD1MXhs1WgtLfO
13. B Zhang, et al. 2007 microRNAs as oncogenes and tumor suppressors Dev Biol 302 1 1 12 16989803 10.1016/j.ydbio.2006.08.028 1:CAS:528: DC%2BD2sXntlOnuw%3D%3D (Pubitemid 46096921)
14. S Subramanian CJ Steer 2010 MicroRNAs as gatekeepers of apoptosis J Cell Physiol 223 2 289 298 20112282 1:CAS:528:DC%2BC3cXisFehsL0%3D
15. BF Yang YJ Lu ZG Wang 2009 MicroRNAs and apoptosis: implications in the molecular therapy of human disease Clin Exp Pharmacol Physiol 36 10 951 960 19566826 10.1111/j.1440-1681.2009.05245.x 1:CAS:528:DC%2BD1MXhsVSktbfE
16. G Marcucci, et al. 2009 MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias Best Pract Res Clin Haematol 22 2 239 248 19698931 10.1016/j.beha.2009.05.003 1:CAS:528:DC%2BD1MXhtVegs7bP
17. Z Li, et al. 2008 Distinct microRNA expression profiles in acute myeloid leukemia with common translocations Proc Natl Acad Sci USA 105 40 15535 15540 18832181 10.1073/pnas.0808266105 1:CAS:528:DC%2BD1cXht1Gnt73E
18. A Dixon-McIver, et al. 2008 Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia PLoS One 3 5 e2141 18478077 10.1371/journal.pone.0002141 (Pubitemid 352025167)
19. R Garzon, et al. 2008 MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia Blood 111 6 3183 3189 18187662 10.1182/blood-2007-07-098749 1:CAS:528:DC%2BD1cXjvVamtbY%3D
20. M Momeny, et al. 2010 Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin Med Oncol 27 3 833 842 19763917 10.1007/s12032-009-9294-9 1:CAS:528:DC%2BC3cXhtVCnu7%2FJ
21. F Xiao, et al. 2009 miRecords: an integrated resource for microRNA-target interactions Nucleic Acids Res 37 Database issue D105 D110 18996891 10.1093/nar/gkn851 1:CAS:528:DC%2BD1cXhsFejt7nE
22. GL Papadopoulos, et al. 2009 DIANA-mirPath: integrating human and mouse microRNAs in pathways Bioinformatics 25 15 1991 1993 19435746 10.1093/bioinformatics/btp299 1:CAS:528:DC%2BD1MXovVektbo%3D
23. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients Blood 89 9 3354 3360 9129042 1:CAS:528:DyaK2sXivVymu7o%3D
24. B Liu, et al. 2009 MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo Lung Cancer 66 2 169 175 19223090 10.1016/j.lungcan.2009.01.010
25. Y Sun, et al. 2010 miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7 Biochem Biophys Res Commun 391 3 1483 1489 20034472 10.1016/j.bbrc.2009.12.098 1:CAS:528:DC%2BC3cXot1ymsg%3D%3D
26. S Li, et al. 2010 Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302 Biol Trace Elem Res 136 3 294 301 19838642 10.1007/s12011-009-8544-1 1:CAS:528:DC%2BC3cXpsVGjtbc%3D
27. G Wang, et al. 2009 Epidermal growth factor receptor-regulated miR-125a-5p-a metastatic inhibitor of lung cancer FEBS J 276 19 5571 5578 19702827 10.1111/j.1742-4658.2009.07238.x 1:CAS:528:DC%2BD1MXhtF2qsL%2FO
28. M Katakowski, et al. 2010 MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma Cancer Invest. 28 1024 1030 20874002 10.3109/07357907.2010.512596 1:CAS:528:DC%2BC3cXhsVeksbvF
29. J Tie, et al. 2010 MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor PLoS Genet 6 3 e1000879 20300657 10.1371/journal.pgen.1000879
30. SW Lane DT Scadden DG Gilliland 2009 The leukemic stem cell niche: current concepts and therapeutic opportunities Blood 114 6 1150 1157 19401558 10.1182/blood-2009-01-202606 1:CAS:528:DC%2BD1MXhtVSgsbbF
31. I Koturbash, et al. 2011 Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis Mutat Res. 722 94 105 20472093 1:CAS:528:DC%2BC3MXntFSqs7o%3D
32. VN Ivanov TK Hei 2006 Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression Exp Cell Res 312 20 4120 4138 17070520 10.1016/j.yexcr.2006.09.019 1:CAS:528:DC%2BD28Xht1Krt7%2FO (Pubitemid 44828055)
33. Y Li, et al. 2009 Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation Cancer Lett 284 2 208 215 19457607 10.1016/j.canlet.2009.04.035 1:CAS:528:DC%2BD1MXhtV2lt7rJ
34. Z Diaz, et al. 2005 Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in APL and other malignant cell lines Blood 105 3 1237 1245 15466933 10.1182/blood-2004-05-1772 1:CAS:528:DC%2BD2MXhtFCgtLw%3D (Pubitemid 40170899)
35. A Saumet, et al. 2009 Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia Blood 113 2 412 421 18941112 10.1182/blood-2008-05-158139 1:CAS:528:DC%2BD1MXptFShsA%3D%3D
36. R Garzon, et al. 2007 MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia Oncogene 26 28 4148 4157 17260024 10.1038/sj.onc.1210186 1:CAS:528:DC%2BD2sXms1Sksbs%3D (Pubitemid 46920170)
37. X Cui, et al. 2008 Metabolism and the paradoxical effects of arsenic: carcinogenesis and anticancer Curr Med Chem 15 22 2293 2304 18781951 10.2174/092986708785747526 1:CAS:528:DC%2BD1MXisFCktr0%3D
38. X Cui, et al. 2006 Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells Hum Pathol 37 3 298 311 16613325 10.1016/j.humpath.2005.10.013 1:CAS:528:DC%2BD28XhvVWgs7s%3D (Pubitemid 43277518)
39. X Zhou, et al. 2008 Arsenite alters global histone H3 methylation Carcinogenesis 29 9 1831 1836 18321869 10.1093/carcin/bgn063 1:CAS:528:DC%2BD1cXhtV2jsL3O
40. B Song, et al. 2010 Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells Mol Cancer 9 96 20433742 10.1186/1476-4598-9-96 1:CAS:528:DC%2BC3cXpt1OntLc%3D
41. CJ Braun, et al. 2008 p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest Cancer Res 68 24 10094 10104 19074875 10.1158/0008-5472.CAN-08-1569 1:CAS:528:DC%2BD1cXhsV2it7bF
42. L Huang, et al. 2011 MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3 Int J Cancer. 128 1758 1769 20549700 10.1002/ijc.25509 1:CAS:528:DC%2BC3MXit1Kgsbo%3D
43. Guan Y et al. MiR-125b targets BCL3 and suppresses ovarian cancer proliferation. Int J Cancer, 2010.
44. SF Tavazoie, et al. 2008 Endogenous human microRNAs that suppress breast cancer metastasis Nature 451 7175 147 152 18185580 10.1038/nature06487 1:CAS:528:DC%2BD1cXksVGhuw%3D%3D
45. HE Rauhala, et al. 2010 miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer Int J Cancer 127 6 1363 1372 20073067 10.1002/ijc.25162 1:CAS:528:DC%2BC3cXpt1Ohsbc%3D
46. Feng R et al. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett, 2010.
47. MW Nasser, et al. 2008 Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1 J Biol Chem 283 48 33394 33405 18818206 10.1074/jbc.M804788200 1:CAS:528:DC%2BD1cXhsVSgt7zF
48. L Jiang, et al. 2010 Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells BMC Cancer 10 318 20569443 10.1186/1471-2407-10-318
49. WC Cho 2010 MicroRNAs in cancer - from research to therapy Biochim Biophys Acta 1805 2 209 217 19931352 1:CAS:528:DC%2BC3cXjt1Kqsrc%3D
50. A Cimmino, et al. 2005 miR-15 and miR-16 induce apoptosis by targeting BCL2 Proc Natl Acad Sci USA 102 39 13944 13949 16166262 10.1073/pnas.0506654102 1:CAS:528:DC%2BD2MXhtVOqsbjK (Pubitemid 41377683)
51. N Bandi, et al. 2009 miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer Cancer Res 69 13 5553 5559 19549910 10.1158/0008-5472.CAN-08-4277 1:CAS:528:DC%2BD1MXnvFajsL4%3D
52. V Mathews, et al. 2010 Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data J Clin Oncol 28 24 3866 3871 20644086 10.1200/JCO.2010.28.5031 1:CAS:528: DC%2BC3cXhtFyhsrfM
53. F Fornari, et al. 2009 MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells Cancer Res 69 14 5761 5767 19584283 10.1158/0008-5472.CAN-08-4797 1:CAS:528:DC%2BD1MXosV2msL0%3D
54. C Gao, et al. 2010 Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer Cancer 116 1 41 49 19890957 1:CAS:528:DC%2BC3cXitFGitb4%3D
55. W Shi, et al. 2010 Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer Int J Cancer 126 9 2036 2048 19739117 1:CAS:528: DC%2BC3cXisFemtb0%3D
56. D Bhaumik, et al. 2008 Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells Oncogene 27 42 5643 5647 18504431 10.1038/onc.2008.171 1:CAS:528:DC%2BD1cXhtFant7%2FE
57. Y Tian, et al. 2010 MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines J Biol Chem 285 11 7986 7994 20075075 10.1074/jbc.M109.062877 1:CAS:528:DC%2BC3cXislyqtb8%3D
58. T Sasayama, et al. 2009 MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC Int J Cancer 125 6 1407 1413 19536818 10.1002/ijc.24522 1:CAS:528:DC%2BD1MXovVels7k%3D
59. PM Borralho, et al. 2009 MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells FEBS J 276 22 6689 6700 19843160 10.1111/j.1742-4658.2009.07383.x 1:CAS:528: DC%2BD1MXhsVSmsLvO
60. Y Akao, et al. 2009 Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells Leuk Res 33 11 1530 1538 19464056 10.1016/j.leukres.2009.04.019 1:CAS:528:DC%2BD1MXhtVegs7jM
61. EK Ng, et al. 2009 MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer Br J Cancer 101 4 699 706 19638978 10.1038/sj.bjc.6605195 1:CAS:528:DC%2BD1MXpvFyisLc%3D
62. Q Wu, et al. 2010 MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2 Biochem Biophys Res Commun 392 3 340 345 20067763 10.1016/j.bbrc.2009.12.182 1:CAS:528:DC%2BC3cXitVGqur0%3D
63. SH Jeong HG Wu WY Park 2009 LIN28B confers radio-resistance through the posttranscriptional control of KRAS Exp Mol Med 41 12 912 918 19745602 10.3858/emm.2009.41.12.097 1:CAS:528:DC%2BC3cXksFarsw%3D%3D
64. S Shimizu, et al. 2010 The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma J Hepatol 52 5 698 704 20347499 10.1016/j.jhep.2009.12.024 1:CAS:528:DC%2BC3cXlsFKksro%3D
65. K Kozaki, et al. 2008 Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer Cancer Res 68 7 2094 2105 18381414 10.1158/0008-5472.CAN-07-5194 1:CAS:528:DC%2BD1cXktVyqtbg%3D (Pubitemid 351521781)
66. S Yu, et al. 2010 miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer Cancer Res 70 14 6015 6025 20610624 10.1158/0008-5472.CAN-09-4531 1:CAS:528:DC%2BC3cXovVamsro%3D
67. G Wang W Mao S Zheng 2008 MicroRNA-183 regulates Ezrin expression in lung cancer cells FEBS Lett 582 25-26 3663 3668 18840437 10.1016/j.febslet.2008.09. 051 1:CAS:528:DC%2BD1cXht12rt7%2FF
68. Zhu W et al. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer, 2010.
69. SA Ciafre, et al. 2005 Extensive modulation of a set of microRNAs in primary glioblastoma Biochem Biophys Res Commun 334 4 1351 1358 16039986 10.1016/j.bbrc.2005.07.030 1:CAS:528:DC%2BD2MXntVOitb8%3D (Pubitemid 41074723)
70. PM Voorhoeve, et al. 2006 A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors Cell 124 6 1169 1181 16564011 10.1016/j.cell.2006.02.037 1:CAS:528:DC%2BD28Xjt1Khsrg%3D
71. WJ Cho, et al. 2009 miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2 Mol Cells 28 6 521 527 19937137 10.1007/s10059-009-0158-0 1:CAS:528:DC%2BC3cXisV2nsw%3D%3D